 David Orlicky
Concepts (967)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver | 56 | 2025 | 1842 | 2.960 |
Why?
| | Pelvic Organ Prolapse | 4 | 2024 | 45 | 2.370 |
Why?
| | Ligaments | 4 | 2024 | 54 | 1.890 |
Why?
| | Cholestasis | 12 | 2023 | 232 | 1.700 |
Why?
| | Mice | 133 | 2025 | 16961 | 1.680 |
Why?
| | Mice, Inbred C57BL | 68 | 2025 | 5455 | 1.520 |
Why?
| | Non-alcoholic Fatty Liver Disease | 10 | 2022 | 260 | 1.480 |
Why?
| | Animals | 182 | 2025 | 35391 | 1.440 |
Why?
| | Ethanol | 19 | 2023 | 591 | 1.430 |
Why?
| | Lipid Metabolism | 18 | 2020 | 503 | 1.420 |
Why?
| | Hepatocytes | 10 | 2024 | 216 | 1.350 |
Why?
| | Liver Diseases, Alcoholic | 10 | 2022 | 89 | 1.220 |
Why?
| | Perilipin-2 | 13 | 2019 | 41 | 1.200 |
Why?
| | Oxidative Stress | 26 | 2024 | 1266 | 1.180 |
Why?
| | Fatty Liver | 13 | 2024 | 230 | 1.110 |
Why?
| | Mice, Knockout | 39 | 2025 | 2881 | 1.100 |
Why?
| | Mast Cells | 5 | 2024 | 142 | 1.010 |
Why?
| | Uterus | 5 | 2024 | 207 | 0.990 |
Why?
| | Receptors, Prostaglandin | 13 | 1998 | 22 | 0.960 |
Why?
| | Bile Acids and Salts | 10 | 2024 | 195 | 0.940 |
Why?
| | Fructose | 10 | 2024 | 106 | 0.930 |
Why?
| | Obesity | 15 | 2023 | 2882 | 0.900 |
Why?
| | Dinoprost | 15 | 1996 | 44 | 0.870 |
Why?
| | Acetaminophen | 6 | 2022 | 247 | 0.840 |
Why?
| | Chemical and Drug Induced Liver Injury | 7 | 2024 | 132 | 0.830 |
Why?
| | Disease Models, Animal | 37 | 2025 | 4078 | 0.820 |
Why?
| | Fatty Liver, Alcoholic | 5 | 2021 | 15 | 0.810 |
Why?
| | Metabolic Syndrome | 7 | 2023 | 340 | 0.810 |
Why?
| | Adipocytes | 6 | 2018 | 204 | 0.720 |
Why?
| | Inflammation | 19 | 2024 | 2750 | 0.720 |
Why?
| | Aldehyde Dehydrogenase | 7 | 2017 | 101 | 0.710 |
Why?
| | Kidney | 10 | 2024 | 1386 | 0.700 |
Why?
| | Fructokinases | 8 | 2023 | 31 | 0.700 |
Why?
| | Receptors, Estrogen | 2 | 2023 | 422 | 0.690 |
Why?
| | Cytoplasm | 6 | 2016 | 269 | 0.680 |
Why?
| | Glutathione | 10 | 2025 | 348 | 0.670 |
Why?
| | Sacrum | 1 | 2020 | 74 | 0.660 |
Why?
| | Aldehydes | 10 | 2022 | 143 | 0.650 |
Why?
| | Protein Carbonylation | 8 | 2018 | 56 | 0.650 |
Why?
| | Milk | 7 | 2019 | 122 | 0.630 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 11 | 0.620 |
Why?
| | Liver Diseases | 6 | 2024 | 290 | 0.610 |
Why?
| | Fructose Intolerance | 3 | 2024 | 4 | 0.600 |
Why?
| | Dietary Fats | 5 | 2022 | 301 | 0.590 |
Why?
| | NF-kappa B | 7 | 2024 | 665 | 0.590 |
Why?
| | Liver Cirrhosis | 9 | 2025 | 281 | 0.570 |
Why?
| | Skin | 9 | 2019 | 727 | 0.570 |
Why?
| | Chemical Warfare Agents | 6 | 2014 | 121 | 0.570 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 4 | 2021 | 217 | 0.560 |
Why?
| | Antioxidants | 10 | 2023 | 558 | 0.550 |
Why?
| | Neoplasm Proteins | 10 | 2005 | 419 | 0.550 |
Why?
| | Cholangitis, Sclerosing | 4 | 2024 | 71 | 0.540 |
Why?
| | Mechlorethamine | 5 | 2015 | 63 | 0.540 |
Why?
| | Lactation | 10 | 2019 | 175 | 0.520 |
Why?
| | Membrane Proteins | 12 | 2016 | 1125 | 0.520 |
Why?
| | Energy Metabolism | 7 | 2024 | 875 | 0.510 |
Why?
| | Carcinoma, Hepatocellular | 3 | 2025 | 272 | 0.510 |
Why?
| | Diet, High-Fat | 9 | 2020 | 239 | 0.500 |
Why?
| | Mammary Glands, Animal | 7 | 2019 | 128 | 0.500 |
Why?
| | Organelles | 2 | 2013 | 54 | 0.500 |
Why?
| | Male | 78 | 2025 | 63671 | 0.490 |
Why?
| | Burns | 3 | 2024 | 288 | 0.490 |
Why?
| | Glutathione Transferase | 6 | 2019 | 102 | 0.490 |
Why?
| | Signal Transduction | 16 | 2024 | 4931 | 0.480 |
Why?
| | Parenteral Nutrition | 5 | 2023 | 104 | 0.480 |
Why?
| | Dioxanes | 3 | 2024 | 7 | 0.470 |
Why?
| | DNA Damage | 8 | 2024 | 384 | 0.470 |
Why?
| | Mitochondria | 6 | 2019 | 876 | 0.450 |
Why?
| | PTEN Phosphohydrolase | 4 | 2018 | 161 | 0.450 |
Why?
| | Ovary | 4 | 2022 | 209 | 0.440 |
Why?
| | Immunity, Innate | 6 | 2024 | 805 | 0.440 |
Why?
| | Colon | 4 | 2024 | 254 | 0.420 |
Why?
| | Liver Neoplasms | 3 | 2025 | 639 | 0.420 |
Why?
| | Prostaglandins F | 6 | 1988 | 17 | 0.410 |
Why?
| | Endotoxemia | 2 | 2024 | 86 | 0.400 |
Why?
| | Alcohol Drinking | 4 | 2016 | 765 | 0.400 |
Why?
| | Macrophages | 7 | 2024 | 1488 | 0.400 |
Why?
| | Cytochrome P-450 CYP2E1 | 5 | 2024 | 25 | 0.390 |
Why?
| | Peptides | 3 | 2008 | 926 | 0.390 |
Why?
| | Alcoholic Intoxication | 2 | 2023 | 63 | 0.380 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2024 | 1202 | 0.380 |
Why?
| | Receptors, Virus | 2 | 2003 | 83 | 0.380 |
Why?
| | Glutamate-Cysteine Ligase | 3 | 2025 | 18 | 0.380 |
Why?
| | Diabetic Nephropathies | 3 | 2024 | 284 | 0.370 |
Why?
| | Superoxide Dismutase | 6 | 2019 | 342 | 0.370 |
Why?
| | Transfection | 8 | 2016 | 915 | 0.360 |
Why?
| | Adenoviridae | 2 | 2003 | 193 | 0.360 |
Why?
| | Female | 61 | 2025 | 68735 | 0.360 |
Why?
| | Oxidation-Reduction | 7 | 2025 | 1028 | 0.360 |
Why?
| | Thioredoxin Reductase 1 | 3 | 2023 | 8 | 0.350 |
Why?
| | Mustard Gas | 5 | 2014 | 110 | 0.350 |
Why?
| | Down Syndrome | 3 | 2023 | 478 | 0.340 |
Why?
| | Endometrium | 6 | 1988 | 56 | 0.340 |
Why?
| | Homocystinuria | 2 | 2024 | 70 | 0.340 |
Why?
| | Salmonella enterica | 2 | 2024 | 55 | 0.340 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2020 | 325 | 0.340 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2017 | 183 | 0.330 |
Why?
| | Lens, Crystalline | 2 | 2022 | 123 | 0.330 |
Why?
| | Humans | 70 | 2025 | 129627 | 0.330 |
Why?
| | Glutathione Reductase | 3 | 2019 | 24 | 0.330 |
Why?
| | Nitric Oxide Synthase Type I | 2 | 2020 | 28 | 0.330 |
Why?
| | Carcinoma, Basal Cell | 2 | 2022 | 74 | 0.330 |
Why?
| | Precancerous Conditions | 2 | 2023 | 160 | 0.330 |
Why?
| | Thioredoxins | 3 | 2018 | 28 | 0.320 |
Why?
| | Fructose-Bisphosphate Aldolase | 3 | 2024 | 8 | 0.320 |
Why?
| | AMP-Activated Protein Kinases | 4 | 2014 | 191 | 0.310 |
Why?
| | Lipids | 7 | 2019 | 627 | 0.310 |
Why?
| | Taste | 2 | 2021 | 216 | 0.300 |
Why?
| | Fallopian Tubes | 2 | 2022 | 30 | 0.300 |
Why?
| | Ultraviolet Rays | 4 | 2022 | 382 | 0.300 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2021 | 285 | 0.300 |
Why?
| | Sevelamer | 2 | 2020 | 9 | 0.300 |
Why?
| | Endothelial Cells | 2 | 2025 | 749 | 0.300 |
Why?
| | Lung Injury | 2 | 2021 | 211 | 0.300 |
Why?
| | Colitis | 2 | 2021 | 243 | 0.300 |
Why?
| | Apoptosis | 11 | 2024 | 2492 | 0.300 |
Why?
| | Rats | 18 | 2022 | 5483 | 0.300 |
Why?
| | Lung | 8 | 2024 | 3938 | 0.300 |
Why?
| | Carbon Tetrachloride | 2 | 2025 | 13 | 0.290 |
Why?
| | Intestinal Mucosa | 4 | 2024 | 590 | 0.290 |
Why?
| | Gene Expression Regulation | 10 | 2021 | 2542 | 0.290 |
Why?
| | Leptin | 2 | 2020 | 220 | 0.280 |
Why?
| | Hibernation | 2 | 2023 | 74 | 0.280 |
Why?
| | Skin Neoplasms | 3 | 2022 | 829 | 0.280 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 5 | 2020 | 23 | 0.280 |
Why?
| | Lipid Peroxidation | 5 | 2014 | 151 | 0.270 |
Why?
| | Kidney Diseases | 2 | 2023 | 383 | 0.270 |
Why?
| | Hepatic Stellate Cells | 2 | 2024 | 12 | 0.260 |
Why?
| | RNA, Messenger | 12 | 2023 | 2708 | 0.260 |
Why?
| | Genetic Vectors | 4 | 2010 | 314 | 0.260 |
Why?
| | Epithelial Cells | 7 | 2022 | 1075 | 0.260 |
Why?
| | Protein Processing, Post-Translational | 5 | 2024 | 457 | 0.260 |
Why?
| | Ileum | 3 | 2024 | 116 | 0.260 |
Why?
| | Triglycerides | 8 | 2021 | 528 | 0.260 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2019 | 432 | 0.250 |
Why?
| | Lipid Droplets | 4 | 2019 | 22 | 0.250 |
Why?
| | Acute Kidney Injury | 2 | 2024 | 791 | 0.250 |
Why?
| | Blister | 4 | 2014 | 41 | 0.250 |
Why?
| | Mice, Hairless | 9 | 2017 | 60 | 0.250 |
Why?
| | Irritants | 2 | 2017 | 48 | 0.250 |
Why?
| | HEK293 Cells | 5 | 2021 | 698 | 0.240 |
Why?
| | I-kappa B Proteins | 2 | 2022 | 79 | 0.240 |
Why?
| | Aldehyde Oxidoreductases | 3 | 2010 | 27 | 0.240 |
Why?
| | Diet, Western | 3 | 2022 | 79 | 0.240 |
Why?
| | Glycoproteins | 4 | 2021 | 338 | 0.240 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2025 | 7 | 0.240 |
Why?
| | Immunohistochemistry | 13 | 2018 | 1685 | 0.240 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2020 | 269 | 0.240 |
Why?
| | Proteomics | 6 | 2024 | 1055 | 0.240 |
Why?
| | Transduction, Genetic | 3 | 2003 | 131 | 0.240 |
Why?
| | Scurvy | 1 | 2025 | 14 | 0.240 |
Why?
| | Wnt-5a Protein | 1 | 2024 | 21 | 0.230 |
Why?
| | Cell-Penetrating Peptides | 1 | 2025 | 21 | 0.230 |
Why?
| | Wnt3A Protein | 1 | 2024 | 10 | 0.230 |
Why?
| | Immunologic Surveillance | 1 | 2025 | 26 | 0.230 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2022 | 566 | 0.230 |
Why?
| | Endoplasmic Reticulum | 5 | 2019 | 261 | 0.230 |
Why?
| | Gentamicins | 1 | 2025 | 54 | 0.230 |
Why?
| | Gastrointestinal Microbiome | 3 | 2024 | 640 | 0.230 |
Why?
| | AMP Deaminase | 1 | 2024 | 10 | 0.230 |
Why?
| | Pancreatic Neoplasms | 4 | 2020 | 880 | 0.230 |
Why?
| | Glycine | 2 | 2016 | 165 | 0.230 |
Why?
| | Gene Dosage | 1 | 2025 | 143 | 0.230 |
Why?
| | Ascorbic Acid | 1 | 2025 | 120 | 0.230 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2024 | 23 | 0.230 |
Why?
| | Tetrahydrofolates | 1 | 2024 | 18 | 0.230 |
Why?
| | Salmonella Phages | 1 | 2024 | 3 | 0.220 |
Why?
| | Paraffin Embedding | 1 | 2024 | 29 | 0.220 |
Why?
| | Prophages | 1 | 2024 | 7 | 0.220 |
Why?
| | Carcinogens | 3 | 2024 | 110 | 0.220 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2024 | 14 | 0.220 |
Why?
| | Cell Line | 14 | 2022 | 2784 | 0.220 |
Why?
| | Silymarin | 2 | 2016 | 199 | 0.220 |
Why?
| | Oxygen | 3 | 2018 | 915 | 0.220 |
Why?
| | Formaldehyde | 1 | 2024 | 60 | 0.220 |
Why?
| | Sphingosine | 1 | 2024 | 40 | 0.220 |
Why?
| | Dietary Sucrose | 2 | 2023 | 48 | 0.220 |
Why?
| | Gene Deletion | 4 | 2018 | 382 | 0.220 |
Why?
| | Lipopolysaccharides | 2 | 2024 | 877 | 0.220 |
Why?
| | Lysophospholipids | 1 | 2024 | 72 | 0.220 |
Why?
| | Glycolipids | 2 | 2016 | 42 | 0.220 |
Why?
| | Tandem Mass Spectrometry | 7 | 2024 | 523 | 0.210 |
Why?
| | Lipoproteins | 2 | 2021 | 172 | 0.210 |
Why?
| | Animals, Newborn | 2 | 2024 | 835 | 0.210 |
Why?
| | Transcription Factor AP-1 | 1 | 2024 | 88 | 0.210 |
Why?
| | Digestive System Diseases | 1 | 2023 | 25 | 0.210 |
Why?
| | NADPH Oxidases | 1 | 2024 | 108 | 0.210 |
Why?
| | Microtubule-Associated Proteins | 5 | 2019 | 192 | 0.210 |
Why?
| | Endodeoxyribonucleases | 1 | 2024 | 67 | 0.210 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2024 | 97 | 0.210 |
Why?
| | Azotemia | 1 | 2023 | 8 | 0.210 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2018 | 627 | 0.210 |
Why?
| | High Fructose Corn Syrup | 1 | 2023 | 8 | 0.210 |
Why?
| | Autophagy | 3 | 2022 | 266 | 0.210 |
Why?
| | Phagocytes | 1 | 2024 | 97 | 0.210 |
Why?
| | Patched-1 Receptor | 2 | 2022 | 16 | 0.210 |
Why?
| | Methionine | 1 | 2024 | 155 | 0.210 |
Why?
| | Estrogen Receptor beta | 1 | 2023 | 38 | 0.210 |
Why?
| | Urinary Tract Infections | 1 | 2025 | 151 | 0.210 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 247 | 0.210 |
Why?
| | Alprostadil | 4 | 1992 | 32 | 0.210 |
Why?
| | Oxidative Phosphorylation | 3 | 2021 | 188 | 0.200 |
Why?
| | Torpor | 1 | 2023 | 14 | 0.200 |
Why?
| | Corpus Luteum | 4 | 1992 | 20 | 0.200 |
Why?
| | Myeloid Cells | 1 | 2024 | 142 | 0.200 |
Why?
| | Herpesvirus 3, Human | 2 | 2021 | 331 | 0.200 |
Why?
| | Antidotes | 2 | 2015 | 136 | 0.200 |
Why?
| | Cell Membrane | 5 | 2016 | 734 | 0.200 |
Why?
| | Catalase | 3 | 2017 | 128 | 0.200 |
Why?
| | Pseudomonas Infections | 1 | 2025 | 223 | 0.200 |
Why?
| | Phospholipids | 2 | 2017 | 216 | 0.200 |
Why?
| | Alcoholism | 2 | 2022 | 765 | 0.200 |
Why?
| | Proteins | 6 | 2013 | 944 | 0.200 |
Why?
| | Dermatitis, Contact | 2 | 2013 | 17 | 0.200 |
Why?
| | Membrane Glycoproteins | 4 | 2021 | 477 | 0.200 |
Why?
| | Immune Tolerance | 1 | 2025 | 356 | 0.200 |
Why?
| | Weight Gain | 4 | 2019 | 509 | 0.200 |
Why?
| | Nucleotides | 2 | 2021 | 122 | 0.200 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2024 | 336 | 0.200 |
Why?
| | Cell Proliferation | 11 | 2020 | 2373 | 0.190 |
Why?
| | Estrogen Receptor alpha | 1 | 2023 | 130 | 0.190 |
Why?
| | Receptors, Androgen | 1 | 2023 | 143 | 0.190 |
Why?
| | Abdominal Injuries | 1 | 2023 | 118 | 0.190 |
Why?
| | Phosphorylation | 6 | 2020 | 1713 | 0.190 |
Why?
| | Thermogenesis | 2 | 2019 | 44 | 0.190 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2022 | 42 | 0.190 |
Why?
| | Hepatitis, Alcoholic | 1 | 2021 | 13 | 0.190 |
Why?
| | Drug Delivery Systems | 1 | 2025 | 333 | 0.190 |
Why?
| | Blotting, Western | 9 | 2015 | 1206 | 0.190 |
Why?
| | Energy Intake | 3 | 2021 | 462 | 0.190 |
Why?
| | Isoxazoles | 1 | 2021 | 54 | 0.190 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2025 | 855 | 0.180 |
Why?
| | Cell Culture Techniques | 2 | 2018 | 338 | 0.180 |
Why?
| | Bacterial Toxins | 1 | 2022 | 104 | 0.180 |
Why?
| | Viral Proteins | 1 | 2024 | 327 | 0.180 |
Why?
| | Phytosterols | 1 | 2021 | 12 | 0.180 |
Why?
| | Colonic Neoplasms | 3 | 2011 | 242 | 0.180 |
Why?
| | Estrogens | 2 | 2023 | 347 | 0.180 |
Why?
| | Neutrophils | 2 | 2024 | 1210 | 0.180 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 51 | 0.180 |
Why?
| | Phenylurea Compounds | 1 | 2022 | 88 | 0.180 |
Why?
| | Drug Resistance | 1 | 2022 | 165 | 0.180 |
Why?
| | Adrenal Glands | 1 | 2021 | 70 | 0.180 |
Why?
| | Glucose | 4 | 2023 | 1002 | 0.180 |
Why?
| | Peroxiredoxins | 2 | 2018 | 24 | 0.180 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2019 | 79 | 0.180 |
Why?
| | Eye | 1 | 2022 | 105 | 0.180 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 19 | 0.180 |
Why?
| | Hepatitis | 2 | 2019 | 47 | 0.180 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 112 | 0.180 |
Why?
| | Fatty Acids | 4 | 2022 | 427 | 0.180 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 24 | 0.180 |
Why?
| | 3T3 Cells | 4 | 2003 | 154 | 0.180 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 32 | 0.180 |
Why?
| | Mucoproteins | 1 | 2020 | 10 | 0.180 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2022 | 232 | 0.170 |
Why?
| | Biomarkers, Tumor | 3 | 2016 | 1164 | 0.170 |
Why?
| | Quinolines | 1 | 2022 | 156 | 0.170 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 3 | 2016 | 57 | 0.170 |
Why?
| | Azetidines | 1 | 2020 | 40 | 0.170 |
Why?
| | Momordica charantia | 1 | 2020 | 15 | 0.170 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2020 | 33 | 0.170 |
Why?
| | Vasopressins | 1 | 2021 | 64 | 0.170 |
Why?
| | Kidney Tubules | 2 | 2019 | 114 | 0.170 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 18 | 0.170 |
Why?
| | Case-Control Studies | 5 | 2020 | 3378 | 0.170 |
Why?
| | Uric Acid | 1 | 2021 | 161 | 0.170 |
Why?
| | Biomarkers | 7 | 2023 | 3968 | 0.170 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2016 | 326 | 0.170 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 127 | 0.170 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 207 | 0.170 |
Why?
| | Herpesviridae Infections | 1 | 2021 | 141 | 0.170 |
Why?
| | Sugars | 1 | 2020 | 36 | 0.170 |
Why?
| | Gene Expression | 2 | 2023 | 1465 | 0.170 |
Why?
| | Monocytes | 2 | 2021 | 553 | 0.170 |
Why?
| | Lysine | 2 | 2024 | 286 | 0.170 |
Why?
| | Myometrium | 1 | 2020 | 37 | 0.170 |
Why?
| | Melanocytes | 1 | 2020 | 65 | 0.170 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 61 | 0.160 |
Why?
| | PPAR alpha | 3 | 2016 | 58 | 0.160 |
Why?
| | Protein Biosynthesis | 3 | 2001 | 410 | 0.160 |
Why?
| | Middle Aged | 11 | 2024 | 31136 | 0.160 |
Why?
| | Up-Regulation | 6 | 2022 | 840 | 0.160 |
Why?
| | Intestines | 3 | 2020 | 347 | 0.160 |
Why?
| | Adipose Tissue | 3 | 2019 | 591 | 0.160 |
Why?
| | Sucrose | 3 | 2018 | 99 | 0.160 |
Why?
| | SNARE Proteins | 1 | 2019 | 39 | 0.160 |
Why?
| | Electron Microscope Tomography | 1 | 2019 | 39 | 0.160 |
Why?
| | Cholesterol | 5 | 2022 | 412 | 0.160 |
Why?
| | Gastrointestinal Motility | 1 | 2019 | 26 | 0.160 |
Why?
| | Cell Adhesion Molecules | 1 | 2020 | 173 | 0.160 |
Why?
| | Deoxycytidine | 1 | 2020 | 164 | 0.160 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 824 | 0.160 |
Why?
| | Cholesterol, Dietary | 1 | 2019 | 18 | 0.160 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 16 | 0.160 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2020 | 1336 | 0.160 |
Why?
| | Acylation | 1 | 2019 | 28 | 0.160 |
Why?
| | Cytokines | 5 | 2022 | 2021 | 0.160 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 530 | 0.160 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2020 | 507 | 0.150 |
Why?
| | Kupffer Cells | 1 | 2019 | 50 | 0.150 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2019 | 64 | 0.150 |
Why?
| | Leishmania major | 1 | 2018 | 8 | 0.150 |
Why?
| | Altitude Sickness | 1 | 2020 | 141 | 0.150 |
Why?
| | Models, Animal | 2 | 2022 | 378 | 0.150 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2020 | 181 | 0.150 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 10 | 0.150 |
Why?
| | Emphysema | 1 | 2019 | 109 | 0.150 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2019 | 187 | 0.150 |
Why?
| | Chromatography, Liquid | 5 | 2024 | 423 | 0.150 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2018 | 13 | 0.150 |
Why?
| | Nitric Oxide | 3 | 2020 | 895 | 0.150 |
Why?
| | Plant Extracts | 1 | 2020 | 199 | 0.150 |
Why?
| | Arteries | 1 | 2020 | 265 | 0.150 |
Why?
| | Carbohydrate Metabolism | 1 | 2018 | 62 | 0.150 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 37 | 0.150 |
Why?
| | Bile Ducts | 1 | 2018 | 68 | 0.150 |
Why?
| | Intestine, Small | 2 | 2020 | 151 | 0.150 |
Why?
| | Protein Kinases | 1 | 2020 | 318 | 0.150 |
Why?
| | Adenocarcinoma | 3 | 2011 | 893 | 0.140 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 31 | 0.140 |
Why?
| | Thyroid Neoplasms | 1 | 2022 | 312 | 0.140 |
Why?
| | Hep G2 Cells | 4 | 2021 | 61 | 0.140 |
Why?
| | Nanoparticles | 1 | 2022 | 375 | 0.140 |
Why?
| | Phenotype | 3 | 2023 | 3075 | 0.140 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 109 | 0.140 |
Why?
| | Cold Temperature | 1 | 2019 | 154 | 0.140 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 4 | 0.140 |
Why?
| | Glucosides | 1 | 2018 | 38 | 0.140 |
Why?
| | Base Sequence | 6 | 2015 | 2147 | 0.140 |
Why?
| | Amino Acid Sequence | 7 | 2020 | 2057 | 0.140 |
Why?
| | Relaxin | 1 | 2017 | 18 | 0.140 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2442 | 0.140 |
Why?
| | Pneumonia | 1 | 2023 | 617 | 0.140 |
Why?
| | Insulin Resistance | 4 | 2019 | 1167 | 0.140 |
Why?
| | Anti-Bacterial Agents | 2 | 2025 | 1705 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2020 | 249 | 0.140 |
Why?
| | Metabolomics | 5 | 2024 | 653 | 0.140 |
Why?
| | Acetyl-CoA Carboxylase | 2 | 2014 | 33 | 0.140 |
Why?
| | Zebrafish Proteins | 1 | 2020 | 268 | 0.140 |
Why?
| | Benzhydryl Compounds | 1 | 2018 | 66 | 0.140 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2017 | 8 | 0.140 |
Why?
| | Virulence Factors | 1 | 2018 | 157 | 0.140 |
Why?
| | Phosgene | 1 | 2017 | 7 | 0.140 |
Why?
| | Cytochrome d Group | 1 | 2016 | 2 | 0.140 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 253 | 0.140 |
Why?
| | Oximes | 1 | 2017 | 22 | 0.140 |
Why?
| | Cytochrome b Group | 1 | 2016 | 19 | 0.130 |
Why?
| | Metabolic Diseases | 1 | 2018 | 104 | 0.130 |
Why?
| | Vasodilation | 1 | 2020 | 476 | 0.130 |
Why?
| | Transcription, Genetic | 3 | 2005 | 1418 | 0.130 |
Why?
| | DNA Primers | 5 | 2015 | 511 | 0.130 |
Why?
| | Sulfonamides | 1 | 2020 | 497 | 0.130 |
Why?
| | Reactive Oxygen Species | 3 | 2022 | 593 | 0.130 |
Why?
| | Sciuridae | 2 | 2023 | 146 | 0.130 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 111 | 0.130 |
Why?
| | Nephrosclerosis | 1 | 2016 | 6 | 0.130 |
Why?
| | Proteome | 2 | 2019 | 438 | 0.130 |
Why?
| | Apocrine Glands | 1 | 2016 | 4 | 0.130 |
Why?
| | Spleen | 2 | 2018 | 509 | 0.130 |
Why?
| | Temperature | 2 | 2018 | 637 | 0.130 |
Why?
| | Xanthine Dehydrogenase | 1 | 2016 | 25 | 0.130 |
Why?
| | Biliary Atresia | 1 | 2018 | 161 | 0.130 |
Why?
| | Cells, Cultured | 10 | 2020 | 4084 | 0.130 |
Why?
| | Cell Differentiation | 7 | 2020 | 1891 | 0.130 |
Why?
| | Necrosis | 2 | 2015 | 232 | 0.130 |
Why?
| | Disease Progression | 6 | 2020 | 2627 | 0.130 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 11 | 0.130 |
Why?
| | Metalloporphyrins | 2 | 2014 | 101 | 0.130 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 47 | 0.130 |
Why?
| | Glycolysis | 3 | 2024 | 315 | 0.130 |
Why?
| | Mice, Obese | 3 | 2023 | 61 | 0.130 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 169 | 0.130 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 79 | 0.130 |
Why?
| | Molecular Sequence Data | 7 | 2015 | 2835 | 0.130 |
Why?
| | Optical Imaging | 1 | 2016 | 56 | 0.130 |
Why?
| | Rabbits | 10 | 2002 | 779 | 0.130 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 1996 | 69 | 0.130 |
Why?
| | Disease Susceptibility | 2 | 2020 | 334 | 0.130 |
Why?
| | Acetylcysteine | 2 | 2022 | 146 | 0.120 |
Why?
| | Zebrafish | 1 | 2020 | 460 | 0.120 |
Why?
| | Choline | 1 | 2017 | 123 | 0.120 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 17 | 0.120 |
Why?
| | Estradiol | 4 | 1988 | 494 | 0.120 |
Why?
| | Epithelium, Corneal | 1 | 2016 | 40 | 0.120 |
Why?
| | Recombinant Proteins | 3 | 2017 | 1308 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 792 | 0.120 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 843 | 0.120 |
Why?
| | Lung Neoplasms | 3 | 2018 | 2342 | 0.120 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2739 | 0.120 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2020 | 752 | 0.120 |
Why?
| | Cell Division | 7 | 1988 | 796 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 733 | 0.120 |
Why?
| | Fibrosis | 4 | 2022 | 526 | 0.120 |
Why?
| | Space Flight | 1 | 2016 | 80 | 0.120 |
Why?
| | Peroxidase | 5 | 2015 | 175 | 0.120 |
Why?
| | Epidermis | 2 | 2014 | 155 | 0.120 |
Why?
| | Down-Regulation | 4 | 2022 | 636 | 0.120 |
Why?
| | Chemokines | 3 | 2023 | 226 | 0.120 |
Why?
| | Pelvis | 1 | 2016 | 104 | 0.120 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 138 | 0.120 |
Why?
| | Mice, Transgenic | 5 | 2021 | 2128 | 0.120 |
Why?
| | Skin Diseases | 1 | 2017 | 143 | 0.120 |
Why?
| | Hematopoietic System | 1 | 2014 | 8 | 0.120 |
Why?
| | MicroRNAs | 1 | 2021 | 679 | 0.120 |
Why?
| | Carcinogenesis | 3 | 2023 | 213 | 0.120 |
Why?
| | Cytoprotection | 2 | 2015 | 56 | 0.120 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 399 | 0.120 |
Why?
| | Interleukin-6 | 3 | 2023 | 723 | 0.110 |
Why?
| | Diet | 3 | 2018 | 1213 | 0.110 |
Why?
| | Aged | 7 | 2024 | 22061 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 887 | 0.110 |
Why?
| | Acetylation | 3 | 2024 | 244 | 0.110 |
Why?
| | Alanine Transaminase | 4 | 2016 | 153 | 0.110 |
Why?
| | Fetal Growth Retardation | 1 | 2020 | 550 | 0.110 |
Why?
| | Homocysteine | 3 | 2024 | 152 | 0.110 |
Why?
| | Body Weight | 5 | 2016 | 940 | 0.110 |
Why?
| | Mice, Inbred ICR | 3 | 2021 | 111 | 0.110 |
Why?
| | Breast Feeding | 1 | 2018 | 423 | 0.110 |
Why?
| | Motor Activity | 1 | 2019 | 676 | 0.110 |
Why?
| | Vagina | 1 | 2016 | 174 | 0.110 |
Why?
| | Adult | 10 | 2024 | 35600 | 0.110 |
Why?
| | Hyperkeratosis, Epidermolytic | 1 | 2014 | 21 | 0.110 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2013 | 8 | 0.110 |
Why?
| | Dermis | 1 | 2014 | 31 | 0.110 |
Why?
| | Metabolism, Inborn Errors | 1 | 2014 | 40 | 0.110 |
Why?
| | Cloning, Molecular | 4 | 2010 | 525 | 0.110 |
Why?
| | Stilbenes | 1 | 2013 | 36 | 0.110 |
Why?
| | Tongue Neoplasms | 1 | 2013 | 24 | 0.110 |
Why?
| | Weight Loss | 1 | 2019 | 738 | 0.110 |
Why?
| | Prediabetic State | 1 | 2016 | 244 | 0.110 |
Why?
| | Methylation | 1 | 2014 | 230 | 0.110 |
Why?
| | Heart | 1 | 2017 | 641 | 0.110 |
Why?
| | Macrophage Activation | 3 | 2023 | 189 | 0.110 |
Why?
| | Kidney Tubules, Proximal | 1 | 2014 | 125 | 0.100 |
Why?
| | Grape Seed Extract | 1 | 2013 | 44 | 0.100 |
Why?
| | Melanoma | 1 | 2020 | 730 | 0.100 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1996 | 149 | 0.100 |
Why?
| | Feces | 3 | 2024 | 442 | 0.100 |
Why?
| | Phosphoproteins | 2 | 2013 | 335 | 0.100 |
Why?
| | Organ Size | 4 | 2016 | 446 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 749 | 0.100 |
Why?
| | Anticarcinogenic Agents | 1 | 2013 | 77 | 0.100 |
Why?
| | Protein Structure, Secondary | 3 | 2018 | 341 | 0.100 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2016 | 149 | 0.100 |
Why?
| | Isoproterenol | 1 | 2013 | 116 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2018 | 816 | 0.100 |
Why?
| | Inositol Phosphates | 3 | 1988 | 22 | 0.100 |
Why?
| | Green Fluorescent Proteins | 3 | 2011 | 388 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 482 | 0.100 |
Why?
| | Lymphopenia | 1 | 2013 | 60 | 0.100 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2013 | 68 | 0.100 |
Why?
| | Coxsackie and Adenovirus Receptor-Like Membrane Protein | 2 | 2003 | 7 | 0.100 |
Why?
| | Microfilament Proteins | 1 | 2013 | 128 | 0.100 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 65 | 0.100 |
Why?
| | Testis | 1 | 1992 | 145 | 0.100 |
Why?
| | Myocardium | 1 | 2017 | 980 | 0.100 |
Why?
| | Mothers | 2 | 2018 | 731 | 0.100 |
Why?
| | Carrier Proteins | 3 | 2017 | 745 | 0.090 |
Why?
| | Cattle | 6 | 2016 | 977 | 0.090 |
Why?
| | Perilipin-3 | 2 | 2008 | 4 | 0.090 |
Why?
| | Mammals | 2 | 2023 | 275 | 0.090 |
Why?
| | DNA, Complementary | 3 | 2016 | 270 | 0.090 |
Why?
| | Arousal | 1 | 2012 | 150 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 21 | 0.090 |
Why?
| | Taurine | 1 | 2011 | 43 | 0.090 |
Why?
| | Eye Proteins | 2 | 2021 | 89 | 0.090 |
Why?
| | Administration, Cutaneous | 3 | 2017 | 124 | 0.090 |
Why?
| | Ligands | 2 | 2023 | 621 | 0.090 |
Why?
| | Olfactory Mucosa | 1 | 2011 | 64 | 0.090 |
Why?
| | Nasal Cavity | 1 | 2011 | 51 | 0.090 |
Why?
| | beta Catenin | 2 | 2024 | 225 | 0.090 |
Why?
| | Microtubules | 1 | 2013 | 263 | 0.090 |
Why?
| | Neurons | 1 | 2019 | 1494 | 0.090 |
Why?
| | Mutation | 3 | 2020 | 3717 | 0.090 |
Why?
| | Acetaldehyde | 1 | 2010 | 17 | 0.090 |
Why?
| | Blood Proteins | 1 | 2012 | 244 | 0.080 |
Why?
| | Cohort Studies | 1 | 2020 | 5426 | 0.080 |
Why?
| | Chenodeoxycholic Acid | 2 | 2021 | 14 | 0.080 |
Why?
| | Luminescent Proteins | 2 | 2001 | 176 | 0.080 |
Why?
| | Heme Oxygenase-1 | 2 | 2021 | 62 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 949 | 0.080 |
Why?
| | Multidrug Resistance-Associated Proteins | 2 | 2021 | 37 | 0.080 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1250 | 0.080 |
Why?
| | Betaine | 2 | 2024 | 75 | 0.080 |
Why?
| | Casein Kinase II | 1 | 2009 | 21 | 0.080 |
Why?
| | COS Cells | 2 | 2003 | 186 | 0.080 |
Why?
| | Protein Folding | 1 | 2011 | 265 | 0.080 |
Why?
| | Immediate-Early Proteins | 1 | 2009 | 51 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 651 | 0.080 |
Why?
| | Peroxiredoxin VI | 1 | 2009 | 5 | 0.080 |
Why?
| | Hyaluronan Receptors | 1 | 2009 | 97 | 0.080 |
Why?
| | Pregnancy | 6 | 2020 | 6417 | 0.080 |
Why?
| | Lysosomes | 2 | 2019 | 137 | 0.080 |
Why?
| | Viral Envelope Proteins | 1 | 2009 | 81 | 0.080 |
Why?
| | Biomarkers, Pharmacological | 1 | 2008 | 26 | 0.080 |
Why?
| | Serine | 1 | 2009 | 138 | 0.080 |
Why?
| | Neoplasm Invasiveness | 3 | 2020 | 481 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 4 | 2016 | 2395 | 0.080 |
Why?
| | Cysteine Proteinase Inhibitors | 2 | 2014 | 50 | 0.080 |
Why?
| | Metabolome | 2 | 2024 | 340 | 0.080 |
Why?
| | Organ Specificity | 3 | 2018 | 296 | 0.080 |
Why?
| | Prospective Studies | 1 | 2020 | 7135 | 0.080 |
Why?
| | Exosomes | 1 | 2009 | 97 | 0.070 |
Why?
| | Oleic Acid | 1 | 2008 | 40 | 0.070 |
Why?
| | Hypertension | 1 | 2017 | 1243 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2008 | 100 | 0.070 |
Why?
| | Structure-Activity Relationship | 2 | 2008 | 545 | 0.070 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2019 | 101 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2019 | 152 | 0.070 |
Why?
| | Tissue Distribution | 3 | 2007 | 315 | 0.070 |
Why?
| | Tumor Suppressor Proteins | 2 | 2020 | 314 | 0.070 |
Why?
| | Adiposity | 2 | 2015 | 504 | 0.070 |
Why?
| | Vasotocin | 1 | 2006 | 5 | 0.070 |
Why?
| | Affinity Labels | 3 | 1992 | 26 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 32 | 0.070 |
Why?
| | Urethane | 1 | 2007 | 41 | 0.070 |
Why?
| | Muscle, Smooth | 2 | 2019 | 161 | 0.070 |
Why?
| | Lipogenesis | 2 | 2018 | 59 | 0.070 |
Why?
| | Muscle Tonus | 1 | 2006 | 21 | 0.070 |
Why?
| | Uterine Contraction | 1 | 2006 | 17 | 0.070 |
Why?
| | Tumor Cells, Cultured | 3 | 2020 | 943 | 0.070 |
Why?
| | Sugar Phosphates | 1 | 1986 | 2 | 0.070 |
Why?
| | Lizards | 1 | 2006 | 34 | 0.070 |
Why?
| | Azides | 3 | 1992 | 46 | 0.070 |
Why?
| | Prostaglandins | 1 | 2006 | 94 | 0.070 |
Why?
| | Risk Factors | 1 | 2020 | 9786 | 0.070 |
Why?
| | Mice, Nude | 2 | 2020 | 682 | 0.060 |
Why?
| | Nitric Oxide Synthase Type II | 3 | 2014 | 171 | 0.060 |
Why?
| | Thermodynamics | 1 | 2008 | 408 | 0.060 |
Why?
| | Amidinotransferases | 2 | 2016 | 2 | 0.060 |
Why?
| | Guanidinoacetate N-Methyltransferase | 2 | 2016 | 4 | 0.060 |
Why?
| | S-Adenosylhomocysteine | 2 | 2016 | 24 | 0.060 |
Why?
| | Kidney Glomerulus | 2 | 2018 | 109 | 0.060 |
Why?
| | L-Gulonolactone Oxidase | 1 | 2025 | 1 | 0.060 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2005 | 14 | 0.060 |
Why?
| | Bone Marrow | 1 | 2007 | 273 | 0.060 |
Why?
| | S-Adenosylmethionine | 2 | 2016 | 55 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 177 | 0.060 |
Why?
| | Sequence Analysis, RNA | 2 | 2018 | 427 | 0.060 |
Why?
| | Diethylnitrosamine | 1 | 2025 | 7 | 0.060 |
Why?
| | DNA Replication | 1 | 1987 | 227 | 0.060 |
Why?
| | Perilipin-1 | 2 | 2019 | 17 | 0.060 |
Why?
| | Chronic Disease | 1 | 2011 | 1720 | 0.060 |
Why?
| | Ovarian Neoplasms | 1 | 2010 | 484 | 0.060 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 460 | 0.060 |
Why?
| | Bacteroidetes | 1 | 2024 | 23 | 0.060 |
Why?
| | Adenoma | 1 | 2007 | 214 | 0.060 |
Why?
| | Cell Transdifferentiation | 1 | 2024 | 31 | 0.060 |
Why?
| | Liver Regeneration | 1 | 2024 | 40 | 0.060 |
Why?
| | Diabetes Mellitus | 2 | 2018 | 1001 | 0.060 |
Why?
| | Fructosephosphates | 1 | 2024 | 1 | 0.060 |
Why?
| | Transcription Factors | 3 | 2019 | 1647 | 0.060 |
Why?
| | Edema | 2 | 2017 | 124 | 0.060 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2024 | 21 | 0.060 |
Why?
| | Ileitis | 1 | 2024 | 32 | 0.060 |
Why?
| | Tissue Fixation | 1 | 2024 | 33 | 0.060 |
Why?
| | Macrophage Activation Syndrome | 1 | 2024 | 21 | 0.060 |
Why?
| | Tamoxifen | 2 | 2020 | 197 | 0.060 |
Why?
| | Oxygen Consumption | 2 | 2018 | 672 | 0.060 |
Why?
| | Polymerase Chain Reaction | 2 | 1998 | 1035 | 0.060 |
Why?
| | Cyclic GMP | 2 | 2019 | 90 | 0.060 |
Why?
| | Diet, Fat-Restricted | 2 | 2015 | 80 | 0.060 |
Why?
| | Rats, Wistar | 2 | 2016 | 442 | 0.060 |
Why?
| | Poly Adenosine Diphosphate Ribose | 1 | 2023 | 2 | 0.050 |
Why?
| | Fingolimod Hydrochloride | 1 | 2024 | 39 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2024 | 57 | 0.050 |
Why?
| | Cystathionine beta-Synthase | 1 | 2024 | 69 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2024 | 53 | 0.050 |
Why?
| | Cyclooxygenase 2 | 2 | 2015 | 176 | 0.050 |
Why?
| | Glycoside Hydrolases | 1 | 2023 | 33 | 0.050 |
Why?
| | Genes, Regulator | 1 | 2023 | 34 | 0.050 |
Why?
| | Time Factors | 5 | 2015 | 6555 | 0.050 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 16 | 0.050 |
Why?
| | Gene Expression Profiling | 3 | 2017 | 1687 | 0.050 |
Why?
| | Macrophages, Alveolar | 1 | 2007 | 389 | 0.050 |
Why?
| | Transcription Factor RelA | 1 | 2024 | 84 | 0.050 |
Why?
| | Mammary Glands, Human | 2 | 2016 | 64 | 0.050 |
Why?
| | Acute-Phase Reaction | 1 | 2023 | 41 | 0.050 |
Why?
| | Furosemide | 1 | 2023 | 40 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 374 | 0.050 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2023 | 24 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 50 | 0.050 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2005 | 226 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 192 | 0.050 |
Why?
| | RNA, Transfer | 1 | 2024 | 130 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2023 | 76 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 170 | 0.050 |
Why?
| | Folic Acid | 1 | 2024 | 184 | 0.050 |
Why?
| | Carbon | 1 | 2024 | 204 | 0.050 |
Why?
| | Interleukin-18 | 1 | 2024 | 237 | 0.050 |
Why?
| | Cell Survival | 4 | 2014 | 1076 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2003 | 179 | 0.050 |
Why?
| | Salmonella typhimurium | 1 | 2024 | 174 | 0.050 |
Why?
| | Chemokine CCL7 | 1 | 2022 | 2 | 0.050 |
Why?
| | Antigens, CD | 2 | 2005 | 487 | 0.050 |
Why?
| | Buthionine Sulfoximine | 1 | 2022 | 8 | 0.050 |
Why?
| | Inhibitor of Apoptosis Proteins | 4 | 2003 | 45 | 0.050 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1996 | 20 | 0.050 |
Why?
| | Pseudomonas aeruginosa | 1 | 2025 | 348 | 0.050 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 183 | 0.050 |
Why?
| | Cervix Uteri | 1 | 2002 | 49 | 0.050 |
Why?
| | Fluorine | 2 | 1992 | 14 | 0.050 |
Why?
| | Rats, Inbred F344 | 2 | 1992 | 259 | 0.050 |
Why?
| | Adenovirus E1A Proteins | 1 | 2001 | 11 | 0.050 |
Why?
| | Sterols | 1 | 2021 | 18 | 0.050 |
Why?
| | Benzimidazoles | 1 | 2023 | 162 | 0.050 |
Why?
| | Nuclear Receptor Co-Repressor 1 | 1 | 2021 | 16 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2007 | 372 | 0.050 |
Why?
| | Adenoviruses, Human | 1 | 2001 | 27 | 0.050 |
Why?
| | Immune Sera | 2 | 1992 | 87 | 0.050 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2002 | 59 | 0.050 |
Why?
| | Dysbiosis | 1 | 2023 | 169 | 0.050 |
Why?
| | Systems Analysis | 1 | 2021 | 21 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2015 | 2011 | 0.050 |
Why?
| | Homeostasis | 2 | 2016 | 605 | 0.050 |
Why?
| | Sodium Glutamate | 1 | 2021 | 9 | 0.050 |
Why?
| | Interferons | 1 | 2023 | 191 | 0.050 |
Why?
| | Intestinal Diseases | 1 | 2021 | 36 | 0.050 |
Why?
| | PAX6 Transcription Factor | 1 | 2021 | 20 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 86 | 0.050 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 149 | 0.050 |
Why?
| | Dilatation | 1 | 2022 | 61 | 0.050 |
Why?
| | Bilirubin | 1 | 2021 | 96 | 0.050 |
Why?
| | Macaca fascicularis | 1 | 2021 | 63 | 0.050 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2002 | 116 | 0.050 |
Why?
| | Infliximab | 1 | 2021 | 101 | 0.050 |
Why?
| | Heme | 1 | 2021 | 77 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2021 | 130 | 0.050 |
Why?
| | Cation Exchange Resins | 1 | 2001 | 7 | 0.050 |
Why?
| | Silicon Dioxide | 1 | 2022 | 109 | 0.050 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2001 | 90 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2021 | 132 | 0.050 |
Why?
| | Histological Techniques | 1 | 2021 | 40 | 0.050 |
Why?
| | Polylysine | 1 | 2001 | 17 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2005 | 1207 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 188 | 0.040 |
Why?
| | Ischemia | 1 | 2024 | 406 | 0.040 |
Why?
| | Indicators and Reagents | 1 | 2001 | 109 | 0.040 |
Why?
| | Drinking | 1 | 2021 | 39 | 0.040 |
Why?
| | Plant Oils | 1 | 2000 | 29 | 0.040 |
Why?
| | Ursodeoxycholic Acid | 1 | 2020 | 19 | 0.040 |
Why?
| | Intestine, Large | 1 | 2020 | 12 | 0.040 |
Why?
| | Crohn Disease | 1 | 2024 | 217 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1109 | 0.040 |
Why?
| | B7-H1 Antigen | 1 | 2022 | 198 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2023 | 400 | 0.040 |
Why?
| | Intercellular Junctions | 1 | 2020 | 39 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2024 | 506 | 0.040 |
Why?
| | Receptors, Purinergic P2X2 | 1 | 2020 | 14 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 183 | 0.040 |
Why?
| | Fluorescence | 1 | 2001 | 155 | 0.040 |
Why?
| | Pyrones | 1 | 2020 | 9 | 0.040 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2020 | 7 | 0.040 |
Why?
| | Receptors, Purinergic P2X3 | 1 | 2020 | 14 | 0.040 |
Why?
| | Morphogenesis | 1 | 2021 | 158 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2020 | 78 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 27 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 317 | 0.040 |
Why?
| | Streptococcus pneumoniae | 1 | 2022 | 161 | 0.040 |
Why?
| | Calcium | 1 | 2006 | 1212 | 0.040 |
Why?
| | DNA-Binding Proteins | 2 | 2019 | 1445 | 0.040 |
Why?
| | Leukocytes | 1 | 2022 | 306 | 0.040 |
Why?
| | Permeability | 1 | 2020 | 157 | 0.040 |
Why?
| | Lactobacillus | 1 | 2020 | 26 | 0.040 |
Why?
| | Cecum | 1 | 2020 | 32 | 0.040 |
Why?
| | RNA | 2 | 2024 | 882 | 0.040 |
Why?
| | Cytomegalovirus | 1 | 2001 | 154 | 0.040 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2020 | 91 | 0.040 |
Why?
| | Feeding Behavior | 2 | 2018 | 622 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2022 | 201 | 0.040 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 28 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2024 | 708 | 0.040 |
Why?
| | Ki-67 Antigen | 2 | 2016 | 108 | 0.040 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 19 | 0.040 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 60 | 0.040 |
Why?
| | Cell Line, Tumor | 3 | 2016 | 3186 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 179 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 117 | 0.040 |
Why?
| | Aging | 2 | 2024 | 1778 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2021 | 372 | 0.040 |
Why?
| | Purines | 1 | 2020 | 172 | 0.040 |
Why?
| | Binding Sites | 1 | 2003 | 1248 | 0.040 |
Why?
| | Pituitary Gland | 1 | 2020 | 148 | 0.040 |
Why?
| | Thiophenes | 1 | 2020 | 117 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2023 | 712 | 0.040 |
Why?
| | Polymers | 2 | 2014 | 477 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 118 | 0.040 |
Why?
| | Interferon-alpha | 1 | 2020 | 194 | 0.040 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2002 | 230 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 15 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 28 | 0.040 |
Why?
| | Food Preferences | 1 | 2020 | 112 | 0.040 |
Why?
| | Cyclin D1 | 1 | 2019 | 63 | 0.040 |
Why?
| | Photoperiod | 1 | 2019 | 46 | 0.040 |
Why?
| | Parasite Load | 1 | 2018 | 8 | 0.040 |
Why?
| | Leishmania donovani | 1 | 2018 | 7 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 39 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2022 | 1042 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2003 | 693 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 142 | 0.040 |
Why?
| | gamma Catenin | 1 | 2018 | 13 | 0.040 |
Why?
| | Protein Binding | 3 | 2011 | 2124 | 0.040 |
Why?
| | Desmoglein 3 | 1 | 2018 | 15 | 0.040 |
Why?
| | Chemoprevention | 1 | 2019 | 91 | 0.040 |
Why?
| | Metaplasia | 1 | 2018 | 57 | 0.040 |
Why?
| | Bronchial Diseases | 1 | 2018 | 37 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2010 | 2133 | 0.040 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2019 | 182 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 87 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2019 | 58 | 0.040 |
Why?
| | Ribosomes | 1 | 2019 | 165 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 74 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 429 | 0.040 |
Why?
| | Cell Respiration | 1 | 2018 | 98 | 0.040 |
Why?
| | Cholic Acids | 1 | 2017 | 17 | 0.040 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 20 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 274 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2018 | 95 | 0.040 |
Why?
| | Oligonucleotides, Antisense | 1 | 1998 | 113 | 0.040 |
Why?
| | Azo Compounds | 1 | 2017 | 26 | 0.040 |
Why?
| | Adiponectin | 2 | 2013 | 235 | 0.040 |
Why?
| | Virulence | 1 | 2018 | 255 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 808 | 0.040 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 191 | 0.030 |
Why?
| | Heart Function Tests | 1 | 2017 | 59 | 0.030 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2017 | 1 | 0.030 |
Why?
| | Adenine | 1 | 2019 | 258 | 0.030 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 69 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.030 |
Why?
| | Pyrazoles | 1 | 2020 | 404 | 0.030 |
Why?
| | Isoenzymes | 1 | 2018 | 301 | 0.030 |
Why?
| | Urinalysis | 1 | 2017 | 75 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2003 | 789 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 161 | 0.030 |
Why?
| | Models, Molecular | 2 | 2013 | 1491 | 0.030 |
Why?
| | Podocytes | 1 | 2017 | 52 | 0.030 |
Why?
| | Immunoenzyme Techniques | 2 | 2011 | 212 | 0.030 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2016 | 20 | 0.030 |
Why?
| | Erythema | 1 | 2017 | 28 | 0.030 |
Why?
| | Staining and Labeling | 2 | 1992 | 142 | 0.030 |
Why?
| | DNA | 5 | 1986 | 1404 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 169 | 0.030 |
Why?
| | Bacteria | 1 | 2023 | 814 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 479 | 0.030 |
Why?
| | Indomethacin | 2 | 2006 | 78 | 0.030 |
Why?
| | Bronchi | 1 | 2018 | 249 | 0.030 |
Why?
| | Butyrophilins | 1 | 2016 | 6 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 494 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2019 | 505 | 0.030 |
Why?
| | Albuminuria | 1 | 2017 | 183 | 0.030 |
Why?
| | Chromosomes, Artificial, Yeast | 1 | 1996 | 4 | 0.030 |
Why?
| | Intracellular Membranes | 1 | 2016 | 83 | 0.030 |
Why?
| | Okadaic Acid | 1 | 1996 | 14 | 0.030 |
Why?
| | Aspartate Aminotransferases | 1 | 2016 | 88 | 0.030 |
Why?
| | Hybrid Cells | 1 | 1996 | 50 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2016 | 92 | 0.030 |
Why?
| | Connective Tissue | 1 | 2016 | 37 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 387 | 0.030 |
Why?
| | Blood Glucose | 2 | 2018 | 2100 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1996 | 151 | 0.030 |
Why?
| | Tissue Array Analysis | 1 | 2016 | 55 | 0.030 |
Why?
| | Lentivirus | 1 | 2016 | 53 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 834 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1011 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1996 | 100 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 1872 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 97 | 0.030 |
Why?
| | Systems Biology | 1 | 2016 | 60 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1833 | 0.030 |
Why?
| | Glucose Intolerance | 1 | 2016 | 142 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 213 | 0.030 |
Why?
| | Deoxyguanosine | 1 | 2015 | 25 | 0.030 |
Why?
| | Chemokine CXCL2 | 1 | 2014 | 43 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2017 | 318 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1996 | 505 | 0.030 |
Why?
| | Catalysis | 1 | 2016 | 310 | 0.030 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 28 | 0.030 |
Why?
| | Tumor Burden | 1 | 2016 | 286 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 636 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1088 | 0.030 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 4 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2014 | 25 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2018 | 584 | 0.030 |
Why?
| | Comet Assay | 1 | 2014 | 17 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1936 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 24 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1159 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2014 | 36 | 0.030 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2014 | 86 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 329 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 611 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2014 | 90 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 388 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 141 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 450 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2014 | 326 | 0.030 |
Why?
| | Skinfold Thickness | 1 | 2013 | 46 | 0.030 |
Why?
| | Kinetics | 3 | 1987 | 1645 | 0.030 |
Why?
| | Progesterone | 2 | 1987 | 245 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2018 | 412 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2013 | 123 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2014 | 119 | 0.030 |
Why?
| | Central Nervous System Depressants | 1 | 2014 | 82 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2016 | 414 | 0.030 |
Why?
| | Tetraspanin 28 | 2 | 2005 | 6 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 1996 | 778 | 0.030 |
Why?
| | Tongue | 1 | 2013 | 76 | 0.030 |
Why?
| | Binding, Competitive | 3 | 1992 | 206 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 24 | 0.030 |
Why?
| | Cell Nucleus | 2 | 2009 | 584 | 0.030 |
Why?
| | Ketone Bodies | 1 | 2013 | 15 | 0.030 |
Why?
| | Nucleic Acid Conformation | 1 | 1996 | 706 | 0.030 |
Why?
| | Computational Biology | 1 | 2017 | 596 | 0.030 |
Why?
| | Leydig Cells | 1 | 1992 | 13 | 0.030 |
Why?
| | Antigens, CD1d | 1 | 2013 | 66 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 28 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 524 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 876 | 0.030 |
Why?
| | Antibody Specificity | 1 | 1993 | 184 | 0.020 |
Why?
| | Theca Cells | 1 | 1992 | 1 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2016 | 569 | 0.020 |
Why?
| | Antibodies | 1 | 2014 | 398 | 0.020 |
Why?
| | Models, Chemical | 1 | 2014 | 263 | 0.020 |
Why?
| | Species Specificity | 1 | 2013 | 574 | 0.020 |
Why?
| | Actins | 1 | 2014 | 411 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2021 | 4894 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2019 | 5756 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2016 | 534 | 0.020 |
Why?
| | alpha-Macroglobulins | 1 | 2012 | 24 | 0.020 |
Why?
| | Models, Biological | 2 | 2011 | 1724 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 1970 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 3774 | 0.020 |
Why?
| | Caseins | 1 | 2011 | 19 | 0.020 |
Why?
| | Palmitic Acid | 1 | 2011 | 40 | 0.020 |
Why?
| | Amino Acids | 1 | 2015 | 487 | 0.020 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 574 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1269 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2013 | 813 | 0.020 |
Why?
| | Serum Albumin | 1 | 2012 | 149 | 0.020 |
Why?
| | Body Temperature | 1 | 2012 | 212 | 0.020 |
Why?
| | Mucous Membrane | 2 | 2002 | 125 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 580 | 0.020 |
Why?
| | Lipase | 1 | 2011 | 66 | 0.020 |
Why?
| | Retinal Dehydrogenase | 1 | 2011 | 30 | 0.020 |
Why?
| | Insulin | 2 | 2016 | 2326 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2011 | 71 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2046 | 0.020 |
Why?
| | Tritium | 1 | 1990 | 75 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 83 | 0.020 |
Why?
| | Cations, Divalent | 1 | 1990 | 53 | 0.020 |
Why?
| | Baculoviridae | 1 | 2010 | 44 | 0.020 |
Why?
| | Blood Pressure | 1 | 2017 | 1736 | 0.020 |
Why?
| | Mitochondria, Liver | 1 | 2010 | 74 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 146 | 0.020 |
Why?
| | Insecta | 1 | 2010 | 64 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 136 | 0.020 |
Why?
| | Hydrolysis | 1 | 1990 | 186 | 0.020 |
Why?
| | Oxidants | 1 | 2010 | 109 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 354 | 0.020 |
Why?
| | NAD | 1 | 2010 | 75 | 0.020 |
Why?
| | Cytosol | 1 | 2010 | 219 | 0.020 |
Why?
| | Histones | 1 | 2015 | 589 | 0.020 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2009 | 29 | 0.020 |
Why?
| | Transgenes | 1 | 2010 | 177 | 0.020 |
Why?
| | Seasons | 1 | 2012 | 494 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 1990 | 107 | 0.020 |
Why?
| | HeLa Cells | 2 | 2001 | 612 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 1084 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 667 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2009 | 110 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1989 | 1087 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 359 | 0.020 |
Why?
| | Prostaglandins F, Synthetic | 1 | 1989 | 9 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2009 | 74 | 0.020 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2008 | 53 | 0.020 |
Why?
| | Administration, Topical | 1 | 2008 | 147 | 0.020 |
Why?
| | Neutrophil Infiltration | 1 | 2008 | 105 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2013 | 660 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1613 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 452 | 0.020 |
Why?
| | Administration, Oral | 1 | 2010 | 787 | 0.020 |
Why?
| | Random Allocation | 1 | 2008 | 347 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 17 | 0.020 |
Why?
| | Cell Movement | 2 | 2009 | 948 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 298 | 0.020 |
Why?
| | Reflex, Stretch | 1 | 2006 | 10 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 611 | 0.020 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2007 | 65 | 0.020 |
Why?
| | Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1986 | 4 | 0.020 |
Why?
| | Vanadium | 1 | 1986 | 4 | 0.020 |
Why?
| | Exercise | 1 | 2018 | 1928 | 0.020 |
Why?
| | Carbachol | 1 | 1986 | 20 | 0.020 |
Why?
| | Vanadates | 1 | 1986 | 14 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2007 | 332 | 0.020 |
Why?
| | Prostaglandins E | 1 | 1986 | 47 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7052 | 0.020 |
Why?
| | Thymidine | 1 | 1986 | 59 | 0.020 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 1986 | 46 | 0.020 |
Why?
| | Growth Substances | 1 | 1986 | 150 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2007 | 371 | 0.020 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1986 | 89 | 0.020 |
Why?
| | Infant | 1 | 2019 | 8995 | 0.020 |
Why?
| | PPAR gamma | 1 | 2007 | 183 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1293 | 0.020 |
Why?
| | Epidermal Growth Factor | 1 | 1986 | 169 | 0.020 |
Why?
| | Tetraspanins | 1 | 2005 | 18 | 0.020 |
Why?
| | Dinoprostone | 1 | 1986 | 187 | 0.020 |
Why?
| | Detergents | 1 | 2005 | 44 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 2009 | 602 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 1986 | 108 | 0.010 |
Why?
| | Cyclic AMP | 1 | 1986 | 238 | 0.010 |
Why?
| | Uteroglobin | 2 | 1984 | 23 | 0.010 |
Why?
| | Solubility | 1 | 2005 | 232 | 0.010 |
Why?
| | Hydrocortisone | 1 | 1987 | 306 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2274 | 0.010 |
Why?
| | Introns | 1 | 2005 | 251 | 0.010 |
Why?
| | Multiprotein Complexes | 1 | 2005 | 155 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 10490 | 0.010 |
Why?
| | Testosterone | 1 | 1987 | 372 | 0.010 |
Why?
| | Metformin | 1 | 2007 | 318 | 0.010 |
Why?
| | Glucagon | 1 | 2003 | 105 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 2 | 1979 | 163 | 0.010 |
Why?
| | Tumor Virus Infections | 1 | 2002 | 46 | 0.010 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2002 | 40 | 0.010 |
Why?
| | Fibroblasts | 1 | 2007 | 953 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2002 | 297 | 0.010 |
Why?
| | Papillomaviridae | 1 | 2002 | 114 | 0.010 |
Why?
| | Photochemistry | 2 | 1992 | 133 | 0.010 |
Why?
| | Fluorescent Dyes | 2 | 1979 | 312 | 0.010 |
Why?
| | Membrane Microdomains | 1 | 2000 | 33 | 0.010 |
Why?
| | Sheep | 3 | 1992 | 845 | 0.010 |
Why?
| | Polyribosomes | 1 | 1980 | 22 | 0.010 |
Why?
| | Molecular Structure | 2 | 1992 | 481 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2000 | 216 | 0.010 |
Why?
| | Hyperplasia | 1 | 2001 | 175 | 0.010 |
Why?
| | Keratins | 1 | 2001 | 175 | 0.010 |
Why?
| | Gestational Age | 1 | 2003 | 876 | 0.010 |
Why?
| | DNA, Viral | 1 | 2002 | 347 | 0.010 |
Why?
| | Thyrotropin | 1 | 1980 | 109 | 0.010 |
Why?
| | Thyroid Gland | 1 | 1980 | 95 | 0.010 |
Why?
| | Cytological Techniques | 1 | 1979 | 27 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 20412 | 0.010 |
Why?
| | Chromomycins | 1 | 1978 | 1 | 0.010 |
Why?
| | Olivomycins | 1 | 1978 | 1 | 0.010 |
Why?
| | Plicamycin | 1 | 1978 | 3 | 0.010 |
Why?
| | Fetus | 1 | 2003 | 774 | 0.010 |
Why?
| | Child | 1 | 2018 | 20884 | 0.010 |
Why?
| | Papillomavirus Infections | 1 | 2002 | 297 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2007 | 1221 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 1978 | 256 | 0.010 |
Why?
| | Polyethylene Glycols | 1 | 2000 | 589 | 0.010 |
Why?
| | Cell Cycle | 1 | 1978 | 588 | 0.010 |
Why?
| | Luteal Cells | 1 | 1992 | 2 | 0.010 |
Why?
| | Esters | 1 | 1992 | 73 | 0.010 |
Why?
| | Chemistry | 1 | 1989 | 45 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1989 | 82 | 0.000 |
Why?
| | Estrogen Antagonists | 1 | 1984 | 46 | 0.000 |
Why?
| | Poly A | 1 | 1980 | 48 | 0.000 |
Why?
| | RNA, Ribosomal | 1 | 1980 | 161 | 0.000 |
Why?
| | Fixatives | 1 | 1978 | 15 | 0.000 |
Why?
| | Leukemia, Experimental | 1 | 1978 | 27 | 0.000 |
Why?
| | Osmolar Concentration | 1 | 1978 | 166 | 0.000 |
Why?
| | Cricetinae | 1 | 1978 | 279 | 0.000 |
Why?
| | Magnesium | 1 | 1978 | 154 | 0.000 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1978 | 541 | 0.000 |
Why?
|
|
Orlicky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|